Carb Counting Hub Carbohydrate counting & diabetes nutrition

Condition

Calorie Tracking and Disordered Eating: A Clinician's Guide

Where the literature stands in 2026, and how clinicians should think about app recommendations for diabetic patients.

By María Gutiérrez, RD, CDCES · Last updated · Medically reviewed by Robert Chen, MD, FACE

Why this article exists

The clinical question we hear most often from endocrinology and CDCES colleagues, posed in supervision and at conference, is some version of the following: a patient with insulin-treated diabetes needs to count carbohydrates to dose insulin safely, and the patient has a personal history of an eating disorder, or shows current warning signs. Should the team recommend a tracking application at all? Which one? What guardrails?

The honest answer, in 2026, is that the literature is mixed, the clinical population is heterogeneous, and the safest defaults are conservative. This article summarises the evidence we believe is most relevant and then sets out a hedged framework for the conversation. It is not a substitute for individualized clinical judgement and is not addressed to patients directly; the audience is the treating endocrinology, CDCES, and behavioural-health team.

What the literature actually shows

The systematic and narrative reviews on calorie- and macronutrient-tracking applications and disordered eating have, since the late 2010s, converged on a context-dependent reading. Findings worth bearing in mind:

The consistent reading across this body of work is that calorie- and macronutrient-tracking applications are not uniformly harmful, are not uniformly safe, and that the modifying variable is the user, not the application. Clinical judgement about the user is therefore the load-bearing decision; application choice is downstream.

The diabetic-specific situation

The diabetic patient cannot simply discontinue carbohydrate tracking the way a non-diabetic patient can. For adults on multiple daily injections (MDI) or insulin pump therapy, carbohydrate counting is a load-bearing safety practice; insulin doses depend on the carbohydrate estimate, and the consequences of under- or over-counting include post-prandial hyperglycemia, hypoglycemia, and cumulative glycemic exposure. The team cannot tell a patient on intensive insulin therapy “stop counting carbs” without offering an alternative dosing strategy.

This is the constraint that makes the diabetic eating-disorder population clinically distinct. The relevant clinical entity here is ED-DMT1 (eating disorder in type 1 diabetes), formerly described under the lay term “diabulimia.” ED-DMT1 specifically refers to the deliberate restriction or omission of insulin doses for the purpose of weight control, often in combination with other eating-disorder behaviours. The condition carries substantial morbidity (recurrent diabetic ketoacidosis, accelerated microvascular complications) and elevated mortality compared with type 1 diabetes alone or with eating disorders alone. ED-DMT1 is increasingly recognised in the endocrinology literature, and the National Diabetes Eating Disorders Awareness clinical referral pathway in the United Kingdom and the parallel structures in other jurisdictions exist precisely because the standard ED treatment pathway and the standard diabetes pathway do not overlap by default.

The behavioural overlap between intensive carbohydrate counting (a clinical necessity) and restrictive or rule-rigid eating (a clinical concern) is real. A patient who counts carbohydrates eight to twelve times a day for insulin dosing is, by the demands of safe insulin therapy, paying close and frequent attention to food composition. The same attention pattern, in a vulnerable patient, can become a vehicle for disordered behaviour rather than a tool for safe dosing.

Warning signs the team should track

We watch for the following in our diabetic patients, particularly in the populations most at risk (adolescent and young-adult women with type 1 diabetes, patients with personal or family history of eating disorders, patients with poorly controlled glycemia and recurrent unexplained DKA):

When we see these signs, the team escalates to behavioural-health partners; the application question is secondary to the clinical question.

Where carb-counting applications fit, and where they do not

Carb-counting applications are tools, and the team’s recommendation should follow the patient’s clinical situation. Our working framework, which we offer for discussion rather than as a prescription:

Within the population of patients for whom an application is appropriate, the relevant trade-off most often discussed in our clinic is between hand-search workflows (typing food names into a database, navigating result lists, selecting portions) and photo-based workflows (taking a picture of the plate and confirming a model-generated estimate). Hand-search workflows have been associated, in the qualitative literature on tracking-app harm, with longer time-on-app, higher frequency of brand-and-portion comparison, and higher reported obsessive-checking behaviour. Photo-based workflows reduce the time-on-app for a given log entry; whether this translates to lower psychological burden in any given individual patient is not yet established by controlled trials, and we would not assert it as a population claim. We mention it in clinic when the trade-off is on the table.

For diabetic patients without a history of disordered eating, photo-based logging may reduce the time-on-app and obsessive-checking patterns associated with hand-search workflows. This is a plausibility argument, not a clinical claim, and the team should not present it as one.

A note on weight conversations

Weight is a relevant clinical variable in diabetes care, and weight conversations cannot always be avoided. We try, where the clinical situation permits, to centre weight conversations on the function (insulin sensitivity, glycemic outcomes, cardiovascular risk markers) rather than on numeric targets, particularly in patients with eating-disorder vulnerability. We avoid framing weight loss as the primary goal of tracking when the patient is at risk.

We do not include numerical body-weight targets, BMI thresholds, or other numeric goals in this article because their presence would be inappropriate to the audience and because the clinical literature on weight conversations in eating-disorder-vulnerable populations supports a function-focused framing.

Limitations of this article

This article is a clinical orientation piece, not a systematic review. The evidence base on tracking-application use in eating-disordered populations is heterogeneous in design, sample, and outcome measure; the evidence base specific to ED-DMT1 is smaller still. We have summarised the direction of the literature and the framework we use in clinic, but reasonable colleagues using the same evidence may reach different operational conclusions. The article is conceptual and is not addressed to patients directly. It does not include numerical body-weight goals, BMI thresholds, restriction protocols, or specific insulin-dosing recommendations; these belong with the treating team.

Where to get help

If you or someone you know is struggling with disordered eating, please reach out for support. You do not have to wait until things are at their worst.

Suggested reading

References

Reviewed by Robert Chen, MD, FACE on . Reviews every clinical guidance article before publication.
Medical disclaimer Content on Carb Counting Hub is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Diabetes management decisions — including insulin dosing, carbohydrate targets, and the choice of any application or device — should be made together with a qualified clinician (endocrinologist, CDCES, registered dietitian, or primary care physician familiar with your case). Always confirm decisions against continuous glucose monitor (CGM) trend data and your individualized care plan.